Annual CAPEX
$53.85 M
+$35.93 M+200.45%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual capital expenditures is currently $53.85 million, with the most recent change of +$35.93 million (+200.45%) on 31 December 2023. During the last 3 years, it has risen by +$49.39 million (+1107.92%). LGND annual CAPEX is now -50.81% below its all-time high of $109.47 million, reached on 31 December 2002.LGND CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$14.24 M
+$12.10 M+565.78%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly capital expenditures is currently $14.24 million, with the most recent change of +$12.10 million (+565.78%) on 30 September 2024. Over the past year, it has increased by +$13.75 million (+2824.23%). LGND quarterly CAPEX is now -86.64% below its all-time high of $106.58 million, reached on 31 December 2002.LGND Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$69.67 M
+$13.75 M+24.60%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated TTM capital expenditures is currently $69.67 million, with the most recent change of +$13.75 million (+24.60%) on 30 September 2024. Over the past year, it has increased by +$65.40 million (+1529.78%). LGND TTM CAPEX is now -36.35% below its all-time high of $109.47 million, reached on 31 December 2002.LGND TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +200.4% | +2824.2% | +1529.8% |
| 3 y3 years | +1107.9% | +703.7% | +750.1% |
| 5 y5 years | +394.6% | - | - |
LGND CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1107.9% | -71.9% | +6915.3% | at high | +1529.8% |
| 5 y | 5 years | at high | +2009.2% | -71.9% | +6915.3% | at high | +8708.2% |
| alltime | all time | -50.8% | >+9999.0% | -86.6% | +303.8% | -36.4% | >+9999.0% |
Ligand Pharmaceuticals Incorporated CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $14.24 M(+565.8%) | $69.67 M(+24.6%) |
| June 2024 | - | $2.14 M(-16.1%) | $55.92 M(+3.6%) |
| Mar 2024 | - | $2.55 M(-95.0%) | $53.98 M(+0.2%) |
| Dec 2023 | $53.85 M(+200.4%) | $50.74 M(>+9900.0%) | $53.85 M(+1159.6%) |
| Sept 2023 | - | $487.00 K(+139.9%) | $4.28 M(-52.9%) |
| June 2023 | - | $203.00 K(-91.6%) | $9.08 M(-41.3%) |
| Mar 2023 | - | $2.41 M(+106.1%) | $15.46 M(-13.7%) |
| Dec 2022 | $17.92 M(+104.6%) | $1.17 M(-77.9%) | $17.92 M(-5.4%) |
| Sept 2022 | - | $5.29 M(-19.7%) | $18.95 M(+22.8%) |
| June 2022 | - | $6.59 M(+35.1%) | $15.43 M(+50.8%) |
| Mar 2022 | - | $4.88 M(+122.1%) | $10.23 M(+16.8%) |
| Dec 2021 | $8.76 M(+96.5%) | $2.19 M(+23.9%) | $8.76 M(+6.9%) |
| Sept 2021 | - | $1.77 M(+27.5%) | $8.20 M(-3.1%) |
| June 2021 | - | $1.39 M(-59.2%) | $8.46 M(+7.6%) |
| Mar 2021 | - | $3.40 M(+108.8%) | $7.86 M(+76.4%) |
| Dec 2020 | $4.46 M(+74.6%) | $1.63 M(-20.0%) | $4.46 M(+57.6%) |
| Sept 2020 | - | $2.04 M(+157.5%) | $2.83 M(+257.5%) |
| June 2020 | - | $791.00 K(-111.3%) | $791.00 K(-96.0%) |
| Dec 2019 | $2.55 M(-76.6%) | - | - |
| Dec 2018 | $10.89 M(+405.0%) | - | - |
| Dec 2017 | $2.16 M(-89.0%) | - | - |
| Dec 2016 | $19.55 M(+79.9%) | -$6.99 M(-419.7%) | $19.55 M(-31.2%) |
| Sept 2016 | - | $2.19 M(-88.3%) | $28.40 M(+3.3%) |
| June 2016 | - | $18.66 M(+228.3%) | $27.49 M(+106.8%) |
| Mar 2016 | - | $5.68 M(+204.8%) | $13.29 M(+22.3%) |
| Dec 2015 | $10.86 M(+141.5%) | $1.86 M(+45.9%) | $10.86 M(-6.0%) |
| Sept 2015 | - | $1.28 M(-71.4%) | $11.56 M(+9.6%) |
| June 2015 | - | $4.46 M(+37.0%) | $10.55 M(+72.1%) |
| Mar 2015 | - | $3.26 M(+27.1%) | $6.13 M(+36.3%) |
| Dec 2014 | $4.50 M(-8.9%) | $2.56 M(+856.3%) | $4.50 M(+53.1%) |
| Sept 2014 | - | $268.00 K(+509.1%) | $2.94 M(+2.2%) |
| June 2014 | - | $44.00 K(-97.3%) | $2.88 M(-55.9%) |
| Mar 2014 | - | $1.62 M(+61.9%) | $6.52 M(+32.1%) |
| Dec 2013 | $4.94 M(-42.9%) | $1.00 M(+389.3%) | $4.94 M(+26.7%) |
| Sept 2013 | - | $205.00 K(-94.4%) | $3.90 M(-48.5%) |
| June 2013 | - | $3.69 M(+9878.4%) | $7.56 M(+83.9%) |
| Mar 2013 | - | $37.00 K(-197.4%) | $4.11 M(-52.4%) |
| Dec 2012 | $8.64 M(+192.7%) | -$38.00 K(-101.0%) | $8.64 M(-25.0%) |
| Sept 2012 | - | $3.87 M(+1500.0%) | $11.52 M(+48.5%) |
| June 2012 | - | $242.00 K(-94.7%) | $7.76 M(+3.2%) |
| Mar 2012 | - | $4.57 M(+61.0%) | $7.52 M(+154.5%) |
| Dec 2011 | $2.95 M(+124.2%) | $2.84 M(+2455.9%) | $2.95 M(<-9900.0%) |
| Sept 2011 | - | $111.00 K(>+9900.0%) | -$12.00 K(-89.8%) |
| June 2011 | - | $0.00(-100.0%) | -$118.00 K(-109.3%) |
| Mar 2011 | - | $5000.00(-103.9%) | $1.27 M(-3.9%) |
| Dec 2010 | $1.32 M(+152.3%) | -$128.00 K(-2660.0%) | $1.32 M(-7.9%) |
| Sept 2010 | - | $5000.00(-99.6%) | $1.43 M(-12.9%) |
| June 2010 | - | $1.38 M(+2371.4%) | $1.64 M(+351.1%) |
| Mar 2010 | - | $56.00 K(-473.3%) | $364.00 K(-30.3%) |
| Dec 2009 | $522.00 K(+5.5%) | -$15.00 K(-106.9%) | $522.00 K(-9.7%) |
| Sept 2009 | - | $217.00 K(+104.7%) | $578.00 K(+34.4%) |
| June 2009 | - | $106.00 K(-50.5%) | $430.00 K(-16.2%) |
| Mar 2009 | - | $214.00 K(+422.0%) | $513.00 K(+3.6%) |
| Dec 2008 | $495.00 K | $41.00 K(-40.6%) | $495.00 K(-5.7%) |
| Sept 2008 | - | $69.00 K(-63.5%) | $525.00 K(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2008 | - | $189.00 K(-3.6%) | $494.00 K(-10.2%) |
| Mar 2008 | - | $196.00 K(+176.1%) | $550.00 K(+25.0%) |
| Dec 2007 | $440.00 K(-75.3%) | $71.00 K(+86.8%) | $440.00 K(-21.4%) |
| Sept 2007 | - | $38.00 K(-84.5%) | $560.00 K(-61.1%) |
| June 2007 | - | $245.00 K(+184.9%) | $1.44 M(-14.2%) |
| Mar 2007 | - | $86.00 K(-55.0%) | $1.68 M(-5.8%) |
| Dec 2006 | $1.78 M(-95.0%) | $191.00 K(-79.2%) | $1.78 M(-4.1%) |
| Sept 2006 | - | $918.00 K(+89.7%) | $1.86 M(-94.7%) |
| June 2006 | - | $484.00 K(+154.7%) | $35.13 M(-0.2%) |
| Mar 2006 | - | $190.00 K(-29.1%) | $35.19 M(-1.1%) |
| Dec 2005 | $35.60 M(+887.7%) | $268.00 K(-99.2%) | $35.60 M(-1.4%) |
| Sept 2005 | - | $34.18 M(+6137.8%) | $36.09 M(+1222.9%) |
| June 2005 | - | $548.00 K(-8.2%) | $2.73 M(-16.0%) |
| Mar 2005 | - | $597.00 K(-21.6%) | $3.25 M(-9.9%) |
| Dec 2004 | $3.60 M(-47.9%) | $761.00 K(-7.4%) | $3.60 M(-57.7%) |
| Sept 2004 | - | $822.00 K(-23.1%) | $8.52 M(+0.3%) |
| June 2004 | - | $1.07 M(+12.3%) | $8.49 M(+11.3%) |
| Mar 2004 | - | $952.00 K(-83.2%) | $7.63 M(+10.3%) |
| Dec 2003 | $6.92 M(-93.7%) | $5.67 M(+612.9%) | $6.92 M(-93.6%) |
| Sept 2003 | - | $796.00 K(+284.5%) | $107.83 M(+0.1%) |
| June 2003 | - | $207.00 K(-13.0%) | $107.74 M(-0.4%) |
| Mar 2003 | - | $238.00 K(-99.8%) | $108.21 M(-1.1%) |
| Dec 2002 | $109.47 M(+5445.3%) | $106.58 M(>+9900.0%) | $109.47 M(+3194.2%) |
| Sept 2002 | - | $709.00 K(+4.9%) | $3.32 M(+18.5%) |
| June 2002 | - | $676.00 K(-54.8%) | $2.81 M(+7.6%) |
| Mar 2002 | - | $1.50 M(+237.5%) | $2.61 M(+32.0%) |
| Dec 2001 | $1.97 M(+81.9%) | $443.00 K(+131.9%) | $1.97 M(+25.0%) |
| Sept 2001 | - | $191.00 K(-60.0%) | $1.58 M(+0.6%) |
| June 2001 | - | $477.00 K(-44.7%) | $1.57 M(-3.1%) |
| Mar 2001 | - | $863.00 K(+1697.9%) | $1.62 M(+49.4%) |
| Dec 2000 | $1.08 M(-54.8%) | $48.00 K(-73.6%) | $1.08 M(-18.8%) |
| Sept 2000 | - | $182.00 K(-65.5%) | $1.34 M(-23.8%) |
| June 2000 | - | $528.00 K(+61.5%) | $1.75 M(-21.2%) |
| Mar 2000 | - | $327.00 K(+9.0%) | $2.23 M(-7.2%) |
| Dec 1999 | $2.40 M(0.0%) | $300.00 K(-50.0%) | $2.40 M(-29.4%) |
| Sept 1999 | - | $600.00 K(-40.0%) | $3.40 M(+209.1%) |
| June 1999 | - | $1.00 M(+100.0%) | $1.10 M(-47.6%) |
| Mar 1999 | - | $500.00 K(-61.5%) | $2.10 M(-12.5%) |
| Dec 1998 | $2.40 M(-44.2%) | $1.30 M(-176.5%) | $2.40 M(+41.2%) |
| Sept 1998 | - | -$1.70 M(-185.0%) | $1.70 M(-52.8%) |
| June 1998 | - | $2.00 M(+150.0%) | $3.60 M(-28.0%) |
| Mar 1998 | - | $800.00 K(+33.3%) | $5.00 M(+16.3%) |
| Dec 1997 | $4.30 M(+975.0%) | $600.00 K(+200.0%) | $4.30 M(+19.4%) |
| Sept 1997 | - | $200.00 K(-94.1%) | $3.60 M(0.0%) |
| June 1997 | - | $3.40 M(+3300.0%) | $3.60 M(+3500.0%) |
| Mar 1997 | - | $100.00 K(-200.0%) | $100.00 K(-75.0%) |
| Dec 1996 | $400.00 K(+100.0%) | -$100.00 K(-150.0%) | $400.00 K(-20.0%) |
| Sept 1996 | - | $200.00 K(-300.0%) | $500.00 K(+66.7%) |
| June 1996 | - | -$100.00 K(-125.0%) | $300.00 K(-25.0%) |
| Mar 1996 | - | $400.00 K(+33.3%) | $400.00 K(-42.9%) |
| Dec 1995 | $200.00 K(-66.7%) | - | - |
| Mar 1995 | - | $300.00 K(0.0%) | $700.00 K(+16.7%) |
| Dec 1994 | $600.00 K | $300.00 K(+200.0%) | $600.00 K(+100.0%) |
| Sept 1994 | - | $100.00 K(>+9900.0%) | $300.00 K(+50.0%) |
| June 1994 | - | $0.00(-100.0%) | $200.00 K(0.0%) |
| Mar 1994 | - | $200.00 K | $200.00 K |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual capital expenditures?
- What is the all time high annual CAPEX for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual CAPEX year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly CAPEX year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM capital expenditures?
- What is the all time high TTM CAPEX for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM CAPEX year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual capital expenditures?
The current annual CAPEX of LGND is $53.85 M
What is the all time high annual CAPEX for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual capital expenditures is $109.47 M
What is Ligand Pharmaceuticals Incorporated annual CAPEX year-on-year change?
Over the past year, LGND annual capital expenditures has changed by +$35.93 M (+200.45%)
What is Ligand Pharmaceuticals Incorporated quarterly capital expenditures?
The current quarterly CAPEX of LGND is $14.24 M
What is the all time high quarterly CAPEX for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly capital expenditures is $106.58 M
What is Ligand Pharmaceuticals Incorporated quarterly CAPEX year-on-year change?
Over the past year, LGND quarterly capital expenditures has changed by +$13.75 M (+2824.23%)
What is Ligand Pharmaceuticals Incorporated TTM capital expenditures?
The current TTM CAPEX of LGND is $69.67 M
What is the all time high TTM CAPEX for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM capital expenditures is $109.47 M
What is Ligand Pharmaceuticals Incorporated TTM CAPEX year-on-year change?
Over the past year, LGND TTM capital expenditures has changed by +$65.40 M (+1529.78%)